Ads
related to: how do intolerance tests work for dementia adults- Doctor Discussion Guide
Learn More About How
To Approach Your Doctor
- Patient Resources
Information About Managing
Agitation in Alzheimer's Dementia.
- Doctor Discussion Guide
groupon.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
The Addenbrooke's Cognitive Examination (ACE) and its subsequent versions (Addenbrooke's Cognitive Examination-Revised, ACE-R and Addenbrooke's Cognitive Examination III, ACE-III) are neuropsychological tests used to identify cognitive impairment in conditions such as dementia.
Test of. Cognitive skill. The Montreal Cognitive Assessment ( MoCA) is a widely used screening assessment for detecting cognitive impairment. [1] It was created in 1996 by Ziad Nasreddine in Montreal, Quebec. It was validated in the setting of mild cognitive impairment (MCI), and has subsequently been adopted in numerous other clinical settings.
Re-testing in 12 months is recommended though. Psychometric properties. The psychometric properties of the GPCOG are good. The reliability of the patient section is high. For the informant interview, reliability is satisfactory. In the original validation sample of 380 participants, the sensitivity of the GPCOG was 0.85, the specificity was
The mini–mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. It is commonly used in medicine and allied health to screen for dementia. It is also used to estimate the severity and progression of cognitive impairment and to ...
The Test of Memory Malingering (TOMM) is a 50-question visual memory recognition test that discriminates between true memory impairment and malingering, with two learning trials and an optional retention trial following a delay. It was first published in 1996 and is intended for testing individuals ages 16 and older.
Clinical Dementia Rating Assignment Qualitative equivalences are as follows:NACC Clinical Dementia Rating. CDR is credited with being able to discern very mild impairments, but its weaknesses include the amount of time it takes to administer, its ultimate reliance on subjective assessment, and relative inability to capture changes over time.